Results 201 to 210 of about 9,423,446 (404)
Italian league against parkinson's disease and extrapyramidal diseases [PDF]
, 1979 openalex +1 more source
Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy
Advanced Therapeutics, EarlyView.This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar +7 more
wiley +1 more source
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. [PDF]
, 1986 Klaus L. Leenders +8 more
openalex +1 more source
Lecithin Alleviates Memory Deficits and Muscle Attenuation in Chinese Older Adults and SAMP8 Mice
Advanced Science, EarlyView.This study opens a new avenue for safeguarding cognition and muscle health, averting disability in older age, and treating age‐related pathologies through lecithin supplementation. It serves as a promising nonpharmacological intervention for the crosstalk of muscle and cognition.
Xianyun Wang +16 more
wiley +1 more source
Advanced Science, EarlyView.Lycium barbarum glycopeptide (LBGP), which is further extracted from Lycium barbarum polysaccharides, exhibits significant protective effects against neomycin‐induced hearing dysfunction including oxidative stress in cochlea and loss of key cells in cochlea.
Yunhao Wu +12 more
wiley +1 more source
Parkinson's disease or Parkinson's diseases?
Biomedicine & Pharmacotherapy, 1999 openaire +3 more sources
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease
, 1974 J. D. Parkes +3 more
openalex +1 more source